Merrimack Pharmaceuticals
MACK
#8010
Rank
โ‚ฌ0.20 B
Marketcap
13,93ย โ‚ฌ
Share price
0.00%
Change (1 day)
3.94%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -0,10ย โ‚ฌ

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -0,10ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,10ย โ‚ฌ an increase over its 2021 EPS that were of -0,17ย โ‚ฌ.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,10ย โ‚ฌ3.08%
2022-0,10ย โ‚ฌ-38.89%
2021-0,17ย โ‚ฌ-25%
2020-0,22ย โ‚ฌ-81.54%
2019-1,20ย โ‚ฌ-56.95%
2018-2,78ย โ‚ฌ-108.5%
201732,70ย โ‚ฌ-390.35%
2016-11,26ย โ‚ฌ-7.35%
2015-12,16ย โ‚ฌ65%
2014-7,37ย โ‚ฌ-39.39%
2013-12,16ย โ‚ฌ-54.01%
2012-26,43ย โ‚ฌ-53.71%
2011-57,11ย โ‚ฌ40.37%
2010-40,68ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
2,93ย โ‚ฌ-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-0,77ย โ‚ฌ 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,31ย โ‚ฌ 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,74ย โ‚ฌ 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-5,19ย โ‚ฌ 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA